Celanese Corporation (CE) is a Chemicals company in the Basic Materials sector, currently trading at $65.10. It has a SharesGrow Score of 31/100, indicating a weak investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CE = $1,513.21 (+2224.4% from the current price, the stock appears undervalued). Analyst consensus target is CE = $62 (-4.4% upside).
Valuation: CE trades at a trailing Price-to-Earnings (P/E) of -6 (S&P 500 average ~25).
Financials: revenue is $9.5B, +-0%/yr average growth. Net income is $1.2B (loss), growing at -50.2%/yr. Net profit margin is -12.2% (negative). Gross margin is 18.8% (-5.8 pp trend).
Balance sheet: total debt is $13.1B against $4.0B equity (Debt-to-Equity (D/E) ratio 3.24, leveraged). Current ratio is 1.55 (strong liquidity). Debt-to-assets is 60.5%. Total assets: $21.7B.
Analyst outlook: 10 / 37 analysts rate CE as buy (27%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 30/100 (Fail), Past 50/100 (Partial), Health 33/100 (Fail), Moat 31/100 (Fail), Future 26/100 (Fail), Income 10/100 (Fail).
